Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $500000.0.

  • Immunocore Holdings' Tax Provisions rose 11891.79% to $500000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 11737.3%. This contributed to the annual value of -$1.8 million for FY2024, which is 6698.2% up from last year.
  • Per Immunocore Holdings' latest filing, its Tax Provisions stood at $500000.0 for Q3 2025, which was up 11891.79% from $606000.0 recorded in Q2 2025.
  • Immunocore Holdings' 5-year Tax Provisions high stood at $1.5 million for Q2 2024, and its period low was -$5.9 million during Q4 2023.
  • Moreover, its 4-year median value for Tax Provisions was $245500.0 (2023), whereas its average is -$455916.7.
  • Data for Immunocore Holdings' Tax Provisions shows a peak YoY increase of 68534.03% (in 2024) and a maximum YoY decrease of 141028.57% (in 2024) over the last 5 years.
  • Over the past 4 years, Immunocore Holdings' Tax Provisions (Quarter) stood at -$289000.0 in 2021, then tumbled by 1945.33% to -$5.9 million in 2023, then surged by 82.24% to -$1.0 million in 2024, then surged by 147.62% to $500000.0 in 2025.
  • Its Tax Provisions stands at $500000.0 for Q3 2025, versus $606000.0 for Q2 2025 and $1.1 million for Q1 2025.